Literature DB >> 7523293

Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium.

M J Wick1, C V Harding, S J Normark, J D Pfeifer.   

Abstract

We investigated parameters that affect the efficiency with which antigenic epitopes from Salmonella typhimurium are processed for presentation to T lymphocytes. As a model system, the hen egg white lysozyme 52-61 [HEL(52-61)] epitope, which binds the murine major histocompatibility complex class II (MHC-II) molecule I-Ak, was expressed in soluble fusion proteins in S. typhimurium. Murine peritoneal macrophages mediated phagocytic processing of viable S. typhimurium expressing fusion proteins of the HEL epitope for presentation via I-Ak regardless of the bacterial compartment in which the epitope was contained (i.e., surface exposed, facing the periplasmic space, or in the cytoplasm). Minor differences in processing efficiency observed with different epitope compartmentalizations could be overcome by altering the relative expression level, indicating that epitope abundance is an important factor for efficient processing of epitopes from S. typhimurium. This processing pathway required phagocytosis of bacteria followed by passage through an acidic compartment, suggesting a pathway involving phagolysosomal degradation of the bacteria to liberate epitopes that bind MHC-II. HEL(52-61) was processed more efficiently from heat-killed S. typhimurium than from viable bacteria, and in addition, the HEL epitope was processed more efficiently from a rough lipopolysaccharide (LPS) strain than from its isogenic smooth LPS counterpart, most likely because of enhanced phagocytosis of the rough LPS strain. These data suggest that the efficiency of epitope processing from S. typhimurium for presentation via MHC-II is affected by bacterial viability, epitope abundance, and LPS phenotype, factors which may be important to consider in development of recombinant S. typhimurium vaccine strains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523293      PMCID: PMC303141          DOI: 10.1128/iai.62.10.4542-4548.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

Authors:  J D Pfeifer; M J Wick; R L Roberts; K Findlay; S J Normark; C V Harding
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

2.  Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping.

Authors:  R G Wilkinson; P Gemski; B A Stocker
Journal:  J Gen Microbiol       Date:  1972-05

Review 3.  Antigen processing and intracellular traffic of antigens and MHC molecules.

Authors:  C V Harding; H J Geuze
Journal:  Curr Opin Cell Biol       Date:  1993-08       Impact factor: 8.382

4.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

Review 5.  Cellular and molecular aspects of antigen processing and the function of class II MHC molecules.

Authors:  C V Harding
Journal:  Am J Respir Cell Mol Biol       Date:  1993-05       Impact factor: 6.914

6.  Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells.

Authors:  M J Wick; J D Pfeifer; K A Findlay; C V Harding; S J Normark
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice.

Authors:  S J Turner; F R Carbone; R A Strugnell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages.

Authors:  N A Buchmeier; C J Lipps; M Y So; F Heffron
Journal:  Mol Microbiol       Date:  1993-03       Impact factor: 3.501

9.  Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes.

Authors:  C M Alpuche Aranda; J A Swanson; W P Loomis; S I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Cosmid cloning and transposon mutagenesis in Salmonella typhimurium using phage lambda vehicles.

Authors:  E T Palva; P Liljeström; S Harayama
Journal:  Mol Gen Genet       Date:  1981
View more
  15 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

2.  Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells.

Authors:  Klaus Panthel; Katrin M Meinel; Victòria E Sevil Domènech; Heike Retzbach; Emeka I Igwe; Wolf-Dietrich Hardt; Holger Rüssmann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The polysaccharide portion of lipopolysaccharide regulates antigen-specific T-cell activation via effects on macrophage-mediated antigen processing.

Authors:  N M Zirk; S F Hashmi; H K Ziegler
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium.

Authors:  Ruwani Sagarika Kalupahana; Pietro Mastroeni; Duncan Maskell; Barbara Ann Blacklaws
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

5.  Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium.

Authors:  R Lo-Man; P Martineau; E Dériaud; S M Newton; M Jehanno; J M Clément; C Fayolle; M Hofnung; C D Leclerc
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.

Authors:  H Chen; D M Schifferli
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.

Authors:  R Lo-Man; J P Langeveld; E Dériaud; M Jehanno; M Rojas; J M Clément; R H Meloen; M Hofnung; C Leclerc
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement.

Authors:  Gerald L Murray; Stephen R Attridge; Renato Morona
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

10.  Changes in Expression of the Membrane Receptors CD14, MHC-II, SR-A, and TLR4 in Tissue-Specific Monocytes/Macrophages Following Porphyromonas gingivalis-LPS Stimulation.

Authors:  Chunfang Wu; Chongwu Liu; Kai Luo; Yanfen Li; Jun Jiang; Fuhua Yan
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.